Risk of Lymphatic filariasis is present in Kenya.
Lymphatic Filariasis, also known as Elephantiasis, is a parasitic infection caused by the Wuchereria bancrofti, Brugia malayi, and Brugia timori nematode worms transmitted to humans through the bite of infected Aedes, Culex, Anopheles, and Mansonia mosquitoes. The disease targets the body's lymphatic system. The infective microscopic larvae (microfilariae) develop in the vector mosquitoes and are injected into humans through a blood meal. In the human host, they reproduce and mature over a period of one year and live in the body for approximately 4 to 6 years. The larvae hatched in humans are ingested by feeding mosquitoes who pass the infection on to another person, continuing the infectious cycle. Lymphatic Filariasis is a Neglected Tropical Disease (NTD)*.
* Neglected Tropical Diseases are chronic infections that are typically endemic in low income countries. They prevent affected adults and children from going to school, working, or fully participating in community life, contributing to stigma and the cycle of poverty.
Lymphatic Filariasis is present in Africa, Central and South America, South Asia, and the Pacific Islands. Long-term travellers, persons on work assignments like humanitarian workers, missionaries, and military personnel staying in endemic areas are at risk.
The majority of cases are asymptomatic – persons do not exhibit symptoms – although the worms can damage kidneys and lymph nodes over a long period of time without signs of illness. A severe infection, which may not show up for years, causes swelling in the genitals, breasts, arms and legs and may progress to lung disease. Treatment includes taking the anthelmintic drugs.
There is no preventive medication or vaccine against Lymphatic Filariasis.
Lymphatic Filariasis nematode images, life cycle, and distribution maps:
Information last updated: January 2020